Showing results (131-140 of 584) with videos related to

Sort By:
Pageof 59
Nature Reviews. Clinical Oncology|August 16, 2018
Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?Gonzalo Recondo, Francesco Facchinetti, Ken A Olaussen, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Symptomatic leptomeningeal metastasis improvement with nivolumab in advanced non-small cell lung cancer patientMaria Gion, Jordi Remon, Caroline Caramella, et al.
Molecular and Clinical Oncology|June 23, 2016
Disseminated intravascular coagulation following administration of sunitinibAnaëlle Olivo, Nicolas Noël, Benjamin Besse, et al.
Investigational New Drugs|February 20, 2016
A never-smoker lung adenocarcinoma patient with a MET exon 14 mutation (D1028N) and a rapid partial response after crizotinibLinda Mahjoubi, Anas Gazzah, Benjamin Besse, et al.
Cancer Treatment Reviews|September 26, 2020
EGFR exon 20 insertions in advanced non-small cell lung cancer: A new history beginsJordi Remon, Lizza E L Hendriks, Andres F Cardona, et al.
Progress in Retinal and Eye Research|September 20, 2024
Ocular adverse events associated with antibody-drug conjugates used in cancer: Focus on pathophysiology and management strategiesEric E Gabison, Antoine Rousseau, Marc Labetoulle, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2020
Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAF<sup>V600E</sup> non-small cell lung cancerFrancesco Facchinetti, Ludovic Lacroix, Laura Mezquita, et al.
The Lancet. Oncology|June 11, 2016
Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trialDavid Planchard, Benjamin Besse, Harry J M Groen, et al.
JCI Insight|May 5, 2022
Targeting genome integrity dysfunctions impedes metastatic potency in non-small cell lung cancer circulating tumor cell-derived explantsTala Tayoun, Vincent Faugeroux, Marianne Oulhen, et al.
Cancers|December 17, 2020
Chronic Plasma Exposure to Kinase Inhibitors in Patients with Oncogene-Addicted Non-Small Cell Lung CancerArthur Geraud, Laura Mezquita, Edouard Auclin, et al.
Pageof 59